RESUMEN
The aim of this study was to investigate whether a nutritional intervention motivating increased vegetable consumption would be an effective treatment and diet therapy for patients with non-alcoholic fatty liver disease. We examined 15 patients with this disease (5 men and 10 women). During the 6-month intervention period, all participants received a small amount of vegetables twice a month as a nutritional education tool aimed at increasing vegetable consumption. They also received nutritional counseling and underwent ultrasound and blood biochemical examinations at baseline and 3 and 6 months after initiation of the intervention. Moreover, they were requested to submit dietary records for any 2 days. Green, white, and total vegetable intakes were significantly higher at 3 and 6 months than at baseline in 8 patients. These patients had significantly lower alanine amino-transferase and triglyceride concentrations than those whose vegetable intake did not increase. Additionally, green vegetable intake significantly negatively correlated with weight at 3 and 6 months (râ =â -0.617, pâ =â 0.032 and râ =â -0.848, pâ =â 0.008, respectively). These results suggest that our nutritional approach effectively increased vegetable consumption in at least some patients with non-alcoholic fatty liver disease, consequently improving their condition.
RESUMEN
We recently reported that 4-methylthio-3-butenyl isothiocyanate (MTBITC) exerts chemopreventive effects on the rat esophageal carcinogenesis model at a low dose of 80 ppm in a diet. In contrast, some isothiocyanates (ITCs) have been reported to cause toxic effects, promotion activity, and/or carcinogenic potential in the urinary bladder of rats. In the present study, we investigated whether MTBITC had toxic effects in the urinary bladder similar to other ITCs, such as phenethyl ITC (PEITC). First, to examine the early toxicity of MTBITC, rats were fed a diet supplemented with 100, 300 or 1000 ppm MTBITC for 14 days. Treatment with 1000 ppm MTBITC caused increased organ weights and histopathological changes in the urinary bladder, producing lesions similar to those of 1000 ppm PEITC. In contrast, rats treated with 100 or 300 ppm MTBITC showed no signs of toxicity. Additionally, we performed in vivo genotoxicity studies to clarify whether MTBITC may exhibit a carcinogenic potential through a genotoxic mechanism in rats. Rats were treated with MTBITC for 3 days at doses of 10, 30 or 90 mg kg-1 body weight by gavage, and comet assays in the urinary bladder and micronucleus assays in the bone marrow were performed. No genotoxic changes were observed after treatment with MTBITC at all doses. Overall, these results suggested that the effects of MTBITC in the rat urinary bladder are less than those of PEITC, but that MTBITC could have toxic effects through a nongenotoxic mechanism in the urinary bladder of rats at high doses. Copyright © 2016 John Wiley & Sons, Ltd.
Asunto(s)
Anticarcinógenos/toxicidad , Isotiocianatos/toxicidad , Mutágenos/toxicidad , Enfermedades de la Vejiga Urinaria/inducido químicamente , Animales , Células de la Médula Ósea/efectos de los fármacos , Daño del ADN , Ingestión de Alimentos/efectos de los fármacos , Masculino , Pruebas de Mutagenicidad , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Endogámicas F344 , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/patología , Enfermedades de la Vejiga Urinaria/genética , Enfermedades de la Vejiga Urinaria/patologíaRESUMEN
To examine the effects of 4-methylthio-3-butenyl isothiocyanate on esophageal carcinogenesis, male 6-week-old F344 rats were subcutaneously injected with 0.5 mg/kg body weight N-nitrosomethylbenzylamine three times per week for 5 weeks and fed a diet supplemented with 80 ppm 4-methylthio-3-butenyl isothiocyanate, equivalent to 6.05 mg/kg body weight/day for the initiation stage, 4.03 mg/kg body weight/day for the promotion stage, or 4.79 mg/kg body weight/day for all stages. Although the incidence of lesions was not affected by 4-methylthio-3-butenyl isothiocyanate treatment, the multiplicity of squamous cell papilloma in the esophagus was significantly decreased in rats in the 4-methylthio-3-butenyl isothiocyanate initiation stage group (1.13 ± 0.74), 4-methylthio-3-butenyl isothiocyanate promotion stage group (1.47 ± 0.99), and 4-methylthio-3-butenyl isothiocyanate all stage group (1.47 ± 1.13) as compared with rats treated with N-nitrosomethylbenzylamine alone (3.00 ± 1.46). Immunohistochemical analysis revealed that 4-methylthio-3-butenyl isothiocyanate induced apoptosis, suppressed cell proliferation, and increased p21 expression when administered in the promotion phase. These modifying effects were not observed in the rats treated with 4-methylthio-3-butenyl isothiocyanate alone. Our results indicated that 4-methylthio-3-butenyl isothiocyanate may exert chemopreventive effects against N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats.
RESUMEN
Six fragrant ingredients were identified in fully-ripened Katsura-uri (Japanese pickling melon; Cucumis melo var. conomon). Four of them were sulfur-containing compounds [methylthioacetic acid ethyl ester (MTAE), acetic acid 2-methylthio ethyl ester (AMTE), 3-methylthiopropionic acid ethyl ester (MTPE), and acetic acid 3-methylthio propyl ester (AMTP)]; and the others were benzyl acetate and eugenol. The newly identified MTAE and AMTP possessed antimutagenic activity as determined by their ability to inhibit the UV-induced mutation in repair-proficient E. coli B/r WP2. MTAE and MTPE (esters with thiocarbonic acid and alkyl alcohol) induced the differentiation of human colon cancer cells (RCM-1 cells), but AMTE and AMTP (esters with carbonic acid and thioalkyl alcohol) did not. A specific thioester motif containing a thiocarbonic acid and alkyl alcohol correlated with these compounds ability to induce differentiation. AMTE, MTPE, AMTP, and eugenol had higher oxygen radical absorbing capacity than the antioxidative vitamin, ascorbic acid. The quantity of MTPE, AMTP and eugenol increased 49-fold, >1175-fold and 11-fold, respectively, in the fully-ripened fruit as compared to the mid-ripened fruit.
Asunto(s)
Anticarcinógenos/farmacología , Antimutagênicos/farmacología , Antioxidantes/farmacología , Diferenciación Celular/efectos de los fármacos , Cucumis melo/química , Odorantes , Línea Celular Tumoral , Neoplasias del Colon , Escherichia coli/genética , Escherichia coli/efectos de la radiación , Humanos , Éteres Metílicos/farmacología , Rayos Ultravioleta/efectos adversosRESUMEN
The fruit of Katsura-uri (Japan's heirloom pickling melon, Cucumis melo var. conomon) possesses a fruity aroma and moderate sweetness. The fruit juice has potential to minimize human postprandial blood glucose levels. This study provides information regarding the health benefits of Katsura-uri and its utility in treating diabetes. The study methodology involved measuring the color and firmness of Katsura-uri fruit at five ripening stages, and quantitation of the aroma substances, proximate composition, and sugars. Significant changes were detected in the color, firmness, and level of aroma substances with ripening of Katsura-uri fruit, albeit with no major changes in proximate composition, with the exception of dietary fiber, and sugars. To determine the effects of Katsura-uri juice, the blood glucose levels of ten diabetic volunteers aged 46-75 y were monitored after its consumption, and compared with after consumption of muskmelon juice equivalent to the total weight of Katsura-uri juice. The blood glucose area under the curve level was significantly lower after consumption of Katsura-uri juice (16±5 h ⢠mg/dL) than after consumption of muskmelon juice (55±17 h ⢠mg/dL; p<0.05). The level of the glucose spike was also significantly lower after consumption of Katsura-uri juice (22±5 mg/dL) than after consumption of muskmelon juice (64±6 mg/dL; p<0.05). The completely ripe Katsura-uri fruit provides the best results for diabetic subjects, which is the first case of fruits sweetened with the addition of zero-calorie sweeteners.
Asunto(s)
Glucemia/metabolismo , Cucumis melo/química , Diabetes Mellitus/tratamiento farmacológico , Jugos de Frutas y Vegetales , Hipoglucemiantes/uso terapéutico , Preparaciones de Plantas/uso terapéutico , Gusto , Anciano , Área Bajo la Curva , Diabetes Mellitus/sangre , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Fibras de la Dieta/análisis , Fibras de la Dieta/farmacología , Fibras de la Dieta/uso terapéutico , Femenino , Frutas/química , Jugos de Frutas y Vegetales/análisis , Humanos , Hiperglucemia/sangre , Hiperglucemia/prevención & control , Hipoglucemiantes/farmacología , Masculino , Persona de Mediana Edad , Odorantes , Preparaciones de Plantas/farmacología , Edulcorantes/farmacología , Edulcorantes/uso terapéuticoRESUMEN
[This corrects the article DOI: 10.1186/s40064-015-1144-y.].
RESUMEN
PURPOSE: We investigated the effect of Katsura-uri (Japanese pickling melon; Cucumis melo var. conomon) on energy metabolism during exercise in human and animal studies. METHODS: Eight healthy men (mean age, 21.4 ± 0.7 years) participated in a single-blind, crossover study. Thirty minutes after ingesting the Katsura-uri drink or placebo drink, they exercised on a cycle ergometer at 40% maximal heart rate for 30 min. Respiratory gas analysis was performed during exercise to examine oxygen consumption and substrate utilization. Blood biochemical parameters were evaluated during exercise. In the animal study, the effect of methylthioacetic acid (MTA), a Katsura-uri derived component was examined in mice. Immediately after running at 25 m/min for 30 min, biochemical parameters in the hind limb muscle and blood of mice were measured. RESULTS: Oxygen consumption during exercise was higher in the Katsura-uri condition (19.8 ± 3.5 mL/kg/min) than the placebo condition (18.6 ± 3.0 mL/kg/min) (P < 0.05). The elevation of blood lactate was lower in the Katsura-uri condition (1.7 ± 0.4 mM) than the placebo condition (2.2 ± 0.6 mM) 15 min after beginning exercise (P < 0.05). There was a higher positive correlation between lactate concentration and carbohydrate oxidation during exercise in the Katsura-uri condition (R(2) = 0.86) compared to the placebo condition (R(2) = 0.47). The decrease in intermuscular pH and the increase in blood lactate following exercise were prevented by MTA supplementation (250 ppm) with significant differences in the MTA-supplemented group compared to the control group. CONCLUSIONS: These results suggest that the ingestion of Katsura-uri and/or MTA improves glucose metabolism and acidification in skeletal muscles during exercise in human and animal studies.